Skip to main content
Clinical Trials/CTRI/2024/10/074700
CTRI/2024/10/074700Not yet recruitingPhase 3

Effect of Kushmanda Taila Uttar Basti in the management of Mutraghata w.s.r. to BPH.

Dr Mohit Bhati1 site in 1 country30 target enrollmentStarted: October 15, 2024Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Reduce the size of prostate.

Study Overview

Brief Summary

Mutraghata is made up of two words i.e. Mutra (urine) and Aghata means obstruction of urinary passage. Hence vayu is responsible for this obstruction so the basic line of treatment is to reduce aggravation of vayu and basti is called ardhachikitsa of vatarogas. So I have selected Uttar basti procedure with Kushmanda Beej Taila which reduces obstruction of urine and makes the flow of urine easy .

Therefore I have selected this trial, there will be 30 patients aged between 40 to 70 years,the patients should be selected on the basis of inclusion and exclusion criteria. The trial will be of 21 days, during trial follow up will be 3 consecutive days with the gap of 3 days. After trial follow up will be done after 15th,30th,45th days after cessation of procedure.

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 70.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • Diagnosed patients of Grade 1 and Grade 2 BPH.
  • Patients aged in between 40 and 70 years.

Exclusion Criteria

  • Patients not having normal PSA value.
  • Patients suffering from acute retention of urine,severe UTI, urethral stricture and bladder and ureteric calculi.
  • Patients having other systemic diseases.
  • Subjects under medications.

Outcomes

Primary Outcomes

Reduce the size of prostate.

Time Frame: 21 days

Secondary Outcomes

  • Relieve in urine obstruction.(After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

Investigators

Sponsor
Dr Mohit Bhati
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Mohit Bhati

Kunwar Shekhar Vijendra Ayurved Medical College and Research center Shobhit University, Gangoh.

Study Sites (1)

Loading locations...

Similar Trials